Nanofabrication has emerged as a revolutionary technique in the pharmaceutical field, offering unprecedented opportunities for the design and development of advanced drug delivery systems and diagnostic tools. This cutting-edge technology involves the precise manipulation of materials at the nanoscale, enabling the creation of nano-sized structures with unique properties. In the pharmaceutical sector, nanofabrication plays a pivotal role in enhancing drug delivery efficiency, minimizing side effects, and improving therapeutic outcomes. Nanoparticles, nanostructured carriers, and nanoscale devices can be engineered to deliver drugs with high precision, targeting specific cells or tissues.
This precision allows for reduced dosage and frequency of administration, addressing concerns related to toxicity and improving patient compliance. Furthermore, nanofabrication facilitates the incorporation of imaging agents and sensors into drug delivery systems, enabling real-time monitoring of drug release and therapeutic response. The versatility of nanofabrication techniques opens avenues for personalized medicine, where treatments can be tailored to individual patient needs. As the pharmaceutical industry continues to explore the vast potential of nanofabrication, it holds the promise of revolutionizing drug development and healthcare practices, ushering in a new era of precision medicine.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia